Berkeley Lights, Inc: Berkeley Lights Launches Opto Plasma B Discovery 4.0 to Accelerate Therapeutic Antibody Discovery Against Difficult Targets
(2) EMERYVILLE, Calif., Jan. 12, 2021 (GLOBE NEWSWIRE) -- Berkeley Lights, Inc. (Nasdaq: BLI), a leader in Digital Cell Biology, today announced the Opto Plasma B Discovery 4.0 workflow. Opto Plasma B Discovery 4.0 is the industry's premier antibody discovery workflow by advancing from B cells to lead molecules in just 1 week. This workflow enables our customers to: Sample 4x more of the relevant biodiversity, screening up to 100,000 cells Functionally test with highly sensitive cell-based assays Recover not only sequences, but also re-expressed molecules without requiring costly gene synth...
Source: finanznachrichten.de